Novartis Bioventures Ltd Insider Trading $BCYC BICYCLE THERAPEUTICS plc
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in BICYCLE THERAPEUTICS plc
Trading Symbol: BCYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 893,195 shares
Latest Transaction: May 30 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in BICYCLE THERAPEUTICS plc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 636,366 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 636,366 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | X | 0.00 | 71,450 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | X | 0.00 | 71,450 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 893,195 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 893,195 | 0 | 0 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 14.00 | 168,630 | 2,360,820 | 1,769,641 | 1.6 M to 1.8 M (+10.53 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 14.00 | 168,630 | 2,360,820 | 1,769,641 | 1.6 M to 1.8 M (+10.53 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 636,366 | 0 | 1,601,011 | 964.6 K to 1.6 M (+65.97 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 636,366 | 0 | 1,601,011 | 964.6 K to 1.6 M (+65.97 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | X | 0.00 | 71,450 | 0 | 964,645 | 893.2 K to 964.6 K (+8.00 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | X | 0.00 | 71,450 | 0 | 964,645 | 893.2 K to 964.6 K (+8.00 %) |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 893,195 | 0 | 893,195 | 0 to 893.2 K |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 893,195 | 0 | 893,195 | 0 to 893.2 K |
Page: 1